Lannett Company, Inc. (NYSE MKT: LCI), a manufacturer of generic
pharmaceuticals, today announced the appointment of James M. Maher to
its Board of Directors, effective July 1, 2013. Maher joins the board
following the retirement of three directors last year. The company's
Board will consist of six members, four of whom will be independent
directors, including Maher.
Maher, 60, spent his entire professional career with
PricewaterhouseCoopers (PwC) LLP. After nearly 40 years with PwC, 30
years as a partner, he retired in June 2012. Most recently, Maher served
as the managing partner of PwC's U.S. assurance practice, comprised of
more than 1,100 partners and 12,000 staff. Previously, he served as the
regional assurance leader for the metro assurance practice. During his
tenure at PwC, Maher worked closely with senior management at several
multinational companies, dealing extensively with significant
acquisitions, divestitures, initial public offerings and secondary
offerings. Maher earned a bachelor's degree in Accounting from C. W.
Post Campus of Long Island University (now LIU Post).
"Jim brings a strong financial background, especially in the areas of
mergers, acquisitions and strategic transactions," said Arthur
Bedrosian, Chief Executive Officer. "His deep experience will support
our company's continued growth. We welcome Jim to our board as we strive
to continue our positive momentum."
About Lannett Company, Inc.:
Lannett Company, founded in 1942, develops, manufactures, packages,
markets and distributes generic pharmaceutical products for a wide range
of medical indications. For more information, visit the company's
website at www.lannett.com.
Robert Jaffe Co., LLC
Robert Jaffe, 424-288-4098